MY PUBLICATIONS

Cranmer, H., Shields, G.E. and Bullement, A., 2022. An investigation into the relationship between choice of model structure and how to adjust for subsequent therapies using a case study in oncology. IN PRINT.​

Podkonjak, T., Cranmer, H., Scarisbrick, J., McCarthy, G., Lilley, C. and Cheng, L.I., 2021. Cost–effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma. Journal of comparative effectiveness research.

Cranmer, H., Podkonjak, T., Benson, E., Dabora, J. and Jackson, G.H., 2020. Delivering Systemic Anti-Cancer Treatment Via Another Route of Administration As an Option to Reduce Exposure to COVID-19 in Patients with Multiple Myeloma in the UK. Blood, 136, pp.12-13.​

Cranmer, H., Shields, G.E. and Bullement, A., 2020. A comparison of partitioned survival analysis and state transition multi-state modelling approaches using a case study in oncology. Journal of Medical Economics, 23(10), pp.1176-1185.​

Bullement, A., Cranmer, H. and Shields, G., 2019. PCN106 A review of decision analytic models to evaluate the cost-effectiveness of cancer treatments: 5-years of publications and single-technology appraisals. Value in Health, 22, pp.S456-S457.​

Cranmer, H., Shields, G. and Bullement, A., 2019. PCN224 Treatment benefit discontinuation: comparison of a partitioned survival analysis and a semi-Markov multi-state model approach using an oncology case study. Value in Health, 22, p.S479.​

Cranmer, H., Shields, G. and Bullement, A., 2019. PCN103 A comparison of partitioner-survival and state transition modelling approaches – finds from a case study in oncology. Value in Health, 22, p.S456.​

Cranmer, H., Shields, G.E. and Bullement, A., 2020. A comparison of partitioned survival analysis and state transition multi-state modelling approaches using a case study in oncology. Journal of Medical Economics, 23(10), pp.1176-1185.​

Cranmer, H., Shields, G. and Bullement, A., 2019. PCN224 Treatment benefit discontinuation: comparison of a partitioned survival analysis and a semi-Markov multi-state model approach using an oncology case study. Value in Health, 22, p.S479.​

Bullement, A., Cranmer, H.L. and Shields, G.E., 2019. A review of recent decision-analytic models used to evaluate the economic value of cancer treatments. Applied health economics and health policy, 17(6), pp.771-780.​